Patents Assigned to United States Department of Health and Human Services, National Institutes of Health
  • USE OF CYSTEAMINE AND DERIVATIVES THEREOF TO SUPPRESS TUMOR METASTASES
    Publication number: 20210290569
    Abstract: The present Disclosure is directed to methods for inhibiting or suppressing metastasis of a tumor in a mammalian subject using a cysteamine product, e.g., cysteamine or cystamine or a derivative thereof. Also described herein is a method for treating pancreatic cancer in a mammalian subject by administering a cysteamine product described herein.
    Type: Application
    Filed: June 2, 2021
    Publication date: September 23, 2021
    Applicants: MESHABERASE, LLC, United States Department of Health and Human Services, National Institutes of Health
    Inventors: Benjamin Rubin, Mark Gilbert, Jinkyu Jung